Announcements Trials
Browse Landscape

Phase

Phase 1 17Phase 2 14Phase 1/2 14Phase EARLY_PHASE1 2Phase 3 2Phase 2/3 2Phase 4 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Melanoma 5Neoplasm Metastasis 2Carcinoma, Renal Cell 2Uveal Melanoma 1Skin Neoplasms 1Sarcoma 1Prostatic Neoplasms 1Motor Activity 1Lymphoid Interstitial Pneumonia 1Laryngeal Diseases 1Carcinoma, Merkel Cell 1Brain Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 4pembrolizumab 2Radiotherapy 2Radiosurgery 2Positron Emission Tomography Computed Tomography 2Ipilimumab 2Cyclophosphamide 2tislelizumab 1teprotumumab 1pazopanib 1lenvatinib 1gallium citrate 1fludarabine phosphate 1fludarabine 1evolocumab 1dexamethasone acetate 1dexamethasone 21-phosphate 1cabozantinib 1auricularum 1aldesleukin 1Spectrum Analysis 1Specimen Handling 1Pemetrexed 1Oxymorphone 1Oxycodone 1Nivolumab 1Morphine 1Levorphanol 1Lapatinib 1Hydromorphone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Neoplasm Metastasis × Ipilimumab × Clear all
NCT05188118 2024-11-06

Rapid Sequencing of Approved Therapies in Patients with Metastatic or Unresectable Clear Cell Renal Cell Carcinoma

Icahn School of Medicine at Mount Sinai

Phase EARLY_PHASE1 Recruiting
20 enrolled
Genitourinary

Carcinoma, Renal Cell, Neoplasm Metastasis

NCT02113657 2024-05-24

T-Cell Responses to Neoantigens Post Treatment With Ipilimumab in Men With Metastatic Castration-Resistant Prostate Cancer

M.D. Anderson Cancer Center

Phase EARLY_PHASE1 Completed
30 enrolled
Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡